secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001193125-26-206578
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Q1 2026 sales $66.6M (+11%), EPS $0.68 (+42%); raises FY guidance
--------------------------------------------------------------------------

- Q1 sales $66.6M (up 11% YoY, 10% organic); gross margin 72.7% (+350 bps); EPS $0.68 (+42%).
- Operating income $17.8M (+41%), op margin 27%; cash grew to $367.2M.
- Artegraft grew 36% worldwide; records for grafts (+20%), valvulotomes (+15%), carotid shunts (+11%).
- Quarterly dividend $0.25/share (payable June 4, record May 21); $100M share repurchase program active.
- FY 2026 guidance: sales $277-283M (mid $280M, +12%), EPS $2.93-3.08 (mid $3.00, +26% adj.).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/d94324d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-206578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer